Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning
about
Interoception and learning: import to understanding and treating diseases and psychopathologiesNegative affective states and cognitive impairments in nicotine dependenceABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice.Donepezil reverses nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6J mice.Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning.Mouse models for studying genetic influences on factors determining smoking cessation success in humans.Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning.Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning.The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation.The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits.Nicotine withdrawal disrupts new contextual learning.Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research.Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 miceModulation of hippocampus-dependent learning and synaptic plasticity by nicotine.Mouse model predicts effects of smoking and varenicline on event-related potentials in humans.Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice.Translational Research on Nicotine Dependence.Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapiesWithdrawal From Chronic Nicotine Reduces Thyroid Hormone Levels and Levothyroxine Treatment Ameliorates Nicotine Withdrawal-Induced Deficits in Hippocampus-Dependent Learning in C57BL/6J Mice.Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation.Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment.Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice.Association of abstinence-induced alterations in working memory function and COMT genotype in smokers.Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice--a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors.Contextual conditioning in rats as an animal model for generalized anxiety disorder.Chronic fluoxetine ameliorates adolescent chronic nicotine exposure-induced long-term adult deficits in trace conditioning.
P2860
Q27013751-4392AF13-F15A-4C67-8D06-25565BAB33DBQ30371220-301CD08A-6B76-4BFB-953A-8FF2500EC988Q30386914-C6320D98-E0A3-4860-93F5-85B502E0DA2AQ30401708-6582AA99-9E61-4BD3-83AD-2A2BFE530558Q30422037-48B18DC1-F21F-46AA-A49E-06C2B85AA261Q30432964-12863183-D77F-4514-812D-E7F8B7CC231BQ30448530-CEC74E7F-E42E-442B-AFEC-6AF980457575Q30455063-5D7BB8F2-AB9A-4918-B93D-BF5F7DC0B8B7Q30455930-723836DF-B122-4E10-955C-A5084A270ED3Q30463325-1EC32744-DC87-49CC-BA3B-D23EFA03C26FQ30480193-FC58AB56-57AA-4FD3-92BE-AD48183716C2Q30485318-E8D12728-37A3-4A10-B4F4-16D8D4FDD5D0Q30485478-37F5E3EA-929C-4B3C-BCBF-C5738DA982B6Q30488170-C07C686B-4A58-49CE-906D-D25CE9FCB5BCQ30489625-5533664F-B0DA-4A5B-8673-2FB2DA5829C0Q33885925-DFBE1963-0D71-4791-9C63-F6366EEC2DCFQ34128836-D7A14140-7C0B-4875-96C2-EDD309C2AF73Q34513939-AE4D15B5-79C8-43EF-93B0-DB7AB1740BE0Q35694111-25A6FB73-8E7B-4764-8745-BDDDE5A3CCFCQ35785041-F76412C0-A11D-48EC-B50B-EB6353DC96ADQ36851620-939C1690-AE0E-4137-8489-FE14990AF059Q37188764-21382F8C-56E0-4E0A-B9D2-EEED5A135043Q37195457-779AF944-F9C7-4970-BE8B-D9E58080814EQ37341565-1D2FCD85-371C-478F-B82C-AA9F9596F209Q37353651-21A44E47-CDC7-44DF-B8BB-0611089C2EC1Q37837718-E6D954DF-DE78-4A37-8A7E-2BD053A1ABA8Q38639906-6263614E-2512-4E21-B55E-EBFC3ACE0389
P2860
Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Bupropion dose-dependently rev ...... n contextual fear conditioning
@ast
Bupropion dose-dependently rev ...... n contextual fear conditioning
@en
type
label
Bupropion dose-dependently rev ...... n contextual fear conditioning
@ast
Bupropion dose-dependently rev ...... n contextual fear conditioning
@en
prefLabel
Bupropion dose-dependently rev ...... n contextual fear conditioning
@ast
Bupropion dose-dependently rev ...... n contextual fear conditioning
@en
P2860
P1476
Bupropion dose-dependently rev ...... n contextual fear conditioning
@en
P2093
George S Portugal
Thomas J Gould
P2860
P304
P356
10.1016/J.PBB.2007.08.004
P407
P577
2007-08-23T00:00:00Z